148 related articles for article (PubMed ID: 23625134)
1. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
Kasatkar P; Ghosh K; Shetty S
Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
[No Abstract] [Full Text] [Related]
2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
[TBL] [Abstract][Full Text] [Related]
4. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P
Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
[TBL] [Abstract][Full Text] [Related]
5. Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome.
Jimenez AR; Vallejo ES; Cruz MZ; Cruz AC; Miramontes JV; Jara BS
Lupus; 2013 Dec; 22(14):1514-7. PubMed ID: 23989733
[TBL] [Abstract][Full Text] [Related]
6. Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
Jackson N; Hashim ZA; Zainal NA; Jamaluddin N
Singapore Med J; 1995 Apr; 36(2):230-1. PubMed ID: 7676276
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of Von Willebrand's syndrome (author's transl)].
Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
[No Abstract] [Full Text] [Related]
8. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
[TBL] [Abstract][Full Text] [Related]
9. The von Willebrand syndrome.
Bloom AL
Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
[No Abstract] [Full Text] [Related]
10. Acquired von Willebrand syndrome in systemic lupus erythematodes.
Michiels JJ; Schroyens W; van der Planken M; Berneman Z
Clin Appl Thromb Hemost; 2001 Apr; 7(2):106-12. PubMed ID: 11292186
[TBL] [Abstract][Full Text] [Related]
11. [Participation of von Willebrand factor in blood platelet functions].
Mikami S; Takahashi Y; Nishino M; Fukui H
Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
[No Abstract] [Full Text] [Related]
12. Acquired von Willebrand syndrome: a rare disorder of heterogeneous etiology.
Kasatkar P; Ghosh K; Shetty S
J Postgrad Med; 2013; 59(2):98-101. PubMed ID: 23793308
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in von Willebrand's disease.
Ruggeri ZM; Zimmerman TS
Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
[No Abstract] [Full Text] [Related]
14. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
16. [Acquired von Willebrand syndrome associated with late onset systemic lupus erythematosus--a case report].
Itoh T; Nakai M; Kitajima N; Kodama K; Takenaka M; Kishihara M; Inatome T; Inoh T; Oomae Y; Shimizu S
Rinsho Ketsueki; 1988 Feb; 29(2):195-202. PubMed ID: 3290540
[No Abstract] [Full Text] [Related]
17. Association of acquired von Willebrand syndrome with AL amyloidosis.
Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
[TBL] [Abstract][Full Text] [Related]
18. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
[No Abstract] [Full Text] [Related]
19. Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease.
Gupta PK; Ahmed R; Kannan M; Chatterjee T; Choudhry VP; Saxena R
Ann Hematol; 2004 Jul; 83(7):489-90. PubMed ID: 15052373
[No Abstract] [Full Text] [Related]
20. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
Brockway WJ; Fass DN
J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
